Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment
Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder cancer, based on the NIAGARA trial.
Personalized Cancer Vaccine Generates Responses Across Cancer Types
PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer, as well as multiple myeloma.
Pelabresib Combo Leads to Outcomes Linked to Better Survival in Myelofibrosis
Pelabresib plus Jakafi led to a reduction in spleen size and was tolerable in patients with myelofibrosis, according to data from MANIFEST-2.
